Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E MacIntyre

Showing results (251-260 of 294) with videos related to

Pageof 30
Sort By:
Neuropharmacology|January 1, 1996
Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferretsF D Tattersall, W Rycroft, B Francis, et al.
Histopathology|August 10, 2000
Distinction between coeliac disease and refractory sprue: a simple immunohistochemical methodN Patey-Mariaud De Serre, C Cellier, B Jabri, et al.
Cytometry. Part B, Clinical Cytometry|October 2, 2014
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter studyC Fossat, M Roussel, I Arnoux, et al.
Leukemia|October 17, 2003
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer programE Beillard, N Pallisgaard, V H J van der Velden, et al.
Neuropharmacology|March 23, 2000
The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferretsF D Tattersall, W Rycroft, M Cumberbatch, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2000
Potent, selective 3-pyridylethanolamine beta3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophoreR J Mathvink, J S Tolman, D Chitty, et al.
Protein Expression and Purification|January 12, 1999
Production of leptin in Escherichia coli: a comparison of methodsJ P Varnerin, T Smith, C I Rosenblum, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2000
Human beta3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamidesL L Brockunier, E R Parmee, H O Ok, et al.
European Journal of Pharmacology|October 26, 2000
L-750355, a human beta3-adrenoceptor agonist; in vitro pharmacology and profile of activity in vivo in the rhesus monkeyM J Forrest, G Hom, T Bach, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
Substituted oxazole benzenesulfonamides as potent human beta3 adrenergic receptor agonistsH O Ok, L B Reigle, M R Candelore, et al.
Pageof 30

Showing results (251-260 of 294) with videos related to

Sort By:
Pageof 30
Neuropharmacology|January 1, 1996
Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferretsF D Tattersall, W Rycroft, B Francis, et al.
Histopathology|August 10, 2000
Distinction between coeliac disease and refractory sprue: a simple immunohistochemical methodN Patey-Mariaud De Serre, C Cellier, B Jabri, et al.
Cytometry. Part B, Clinical Cytometry|October 2, 2014
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter studyC Fossat, M Roussel, I Arnoux, et al.
Leukemia|October 17, 2003
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer programE Beillard, N Pallisgaard, V H J van der Velden, et al.
Neuropharmacology|March 23, 2000
The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferretsF D Tattersall, W Rycroft, M Cumberbatch, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2000
Potent, selective 3-pyridylethanolamine beta3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophoreR J Mathvink, J S Tolman, D Chitty, et al.
Protein Expression and Purification|January 12, 1999
Production of leptin in Escherichia coli: a comparison of methodsJ P Varnerin, T Smith, C I Rosenblum, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2000
Human beta3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamidesL L Brockunier, E R Parmee, H O Ok, et al.
European Journal of Pharmacology|October 26, 2000
L-750355, a human beta3-adrenoceptor agonist; in vitro pharmacology and profile of activity in vivo in the rhesus monkeyM J Forrest, G Hom, T Bach, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
Substituted oxazole benzenesulfonamides as potent human beta3 adrenergic receptor agonistsH O Ok, L B Reigle, M R Candelore, et al.
Pageof 30